KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) EBT Margin (2020 - 2025)

Clover Health Investments (CLOV) has disclosed EBT Margin for 6 consecutive years, with 9.15% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 1542.0% year-over-year to 9.15%, compared with a TTM value of 0.29% through Dec 2025, up 362.0%, and an annual FY2025 reading of 17.08%, up 2042.0% over the prior year.
  • EBT Margin was 9.15% for Q4 2025 at Clover Health Investments, up from 4.91% in the prior quarter.
  • Across five years, EBT Margin topped out at 9.15% in Q4 2025 and bottomed at 73.49% in Q3 2021.
  • Average EBT Margin over 5 years is 16.4%, with a median of 6.64% recorded in 2024.
  • The sharpest move saw EBT Margin crashed -7212bps in 2021, then surged 6830bps in 2022.
  • Year by year, EBT Margin stood at 28.55% in 2021, then soared by 58bps to 11.88% in 2022, then rose by 28bps to 8.6% in 2023, then grew by 27bps to 6.27% in 2024, then skyrocketed by 246bps to 9.15% in 2025.
  • Business Quant data shows EBT Margin for CLOV at 9.15% in Q4 2025, 4.91% in Q3 2025, and 2.19% in Q2 2025.